DVAX
Dynavax Technologies Corp
Price:  
10.56 
USD
Volume:  
1,043,730.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DVAX EV/EBITDA

-126.0%
Upside

As of 2024-07-15, the EV/EBITDA ratio of Dynavax Technologies Corp (DVAX) is -119.80. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DVAX's latest enterprise value is 1,473.15 mil USD. DVAX's TTM EBITDA according to its financial statements is -12.30 mil USD. Dividing these 2 quantities gives us the above DVAX EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 15.2x - 24.3x 19.9x
Forward P/E multiples 20.8x - 24.7x 23.7x
Fair Price (2.65) - (2.98) (2.74)
Upside -125.0% - -128.2% -126.0%
10.56 USD
Stock Price
(2.74) USD
Fair Price

DVAX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-07-15 -119.80
2024-07-12 -121.82
2024-07-11 -119.27
2024-07-10 -120.22
2024-07-09 -124.27
2024-07-08 -126.40
2024-07-05 -127.14
2024-07-03 -124.69
2024-07-02 -125.33
2024-07-01 -126.18
2024-06-28 -126.93
2024-06-27 -128.42
2024-06-26 -124.69
2024-06-25 -126.72
2024-06-24 -128.74
2024-06-21 -129.06
2024-06-20 -127.14
2024-06-18 -127.46
2024-06-17 -128.10
2024-06-14 -130.34
2024-06-13 -135.23
2024-06-12 -136.19
2024-06-11 -136.08
2024-06-10 -135.87
2024-06-07 -135.76
2024-06-06 -138.00
2024-06-05 -136.19
2024-06-04 -135.98
2024-06-03 -138.53
2024-05-31 -135.02
2024-05-30 -133.21
2024-05-29 -130.12
2024-05-28 -129.80
2024-05-24 -128.63
2024-05-23 -133.53
2024-05-22 -133.85
2024-05-21 -129.38
2024-05-20 -128.63
2024-05-17 -125.65
2024-05-16 -127.46
2024-05-15 -124.91
2024-05-14 -124.48
2024-05-13 -124.80
2024-05-10 -121.61
2024-05-09 -124.59
2024-05-08 -131.40
2024-05-07 -132.57
2024-05-06 -131.29
2024-05-03 -132.36
2024-05-02 -132.14